Aberrations of growth factors as biomarkers of cancer progression

Archive of Oncology

Volumn 13, Issue 3-4, 2005, Pages 121-123

  Ivanović, Vesna ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Carcinoma; Disease Progression; Oncogene Proteins; Receptor, Epidermal Growth Factor; Transforming Growth Factor beta; Tumor Markers, Biological

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR BETA; GROWTH FACTOR; GROWTH INHIBITOR; MOLECULAR MARKER; ONCOPROTEIN; RECEPTOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

BREAST CANCER; CANCER MORTALITY; CANCER RESEARCH; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CONFERENCE PAPER; GENE CONTROL; GENE DISRUPTION; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENETIC TRANSDUCTION; HEALTH SURVEY; LUNG CANCER; MEDICAL LITERATURE; PROSTATE CANCER;

EID: 33645766245     PISSN: 03547310     EISSN: None     Source Type: Journal    
DOI: 10.2298/AOO0504121I     Document Type: Conference Paper

References (20)

1. Pritzker KPH, Azad A. Genomic biomarkers for cancer assessment: Implementation challenges for laboratory practice. Clin Biochem 2001;37:642-6.
2. Robinson JE, Perreard L, Bernard PS. State of the science: molecular classifications of breast cancer for clinical diagnostics. Clin Biohem 2004;37:572-8.
3. Kaminski N, Krupsky M. Gene Expression Pattern, Prognostic and Diagnostic Markers, and Lung Cancer Biology. Chest 2004;125:111S-5S.
4. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, et al. Analysis of Gene Expression Identifies Candidate Markers and Pharmacological Targets in Prostate Cancer. Cancer Res 2001;61:5974-8.
5. Hunter T. Oncoprotein Networks. Cell 1997;88:333-46.
6. Elliott RL, Blobe GC. Role of Transforming Growth Factor Beta in Human Cancer. J Clin Oncol 2005;23:2078-93.
7. Kim IY, KIm MM, Kim SJ. Transforming Growth Factor-β: Biology and Clinical Relevance. J Biochem Mol Biol 2005;38(1):1-8.
8. Benson JR. Role of transforming growth factor β in breast carcinogenesis. Lancet Oncol 2004;5:229-39.
9. 1 in patients with invasive prostate cancer. Nat Med 1995;1(4):282-4.
10. 1 as a prognostic biomarker of prostate carcinoma. Arch Oncol 1998;6:159-62.
11. 1) in human plasma - a pilot study on breast cancer patients. Jugoslav Med Biochem 2001;19:81-7.
12. 1) in Patients with Advanced Breast Cancer: Association with Disease Progression. Eur J Cancer 2003;39:454-61.
13. 1) and TGFβ receptor type II: possible implications in breast cancer. Med Hypotheses 2004;62:727-32.
14. 1-related survival of postmenopausal metastatic breast cancer patients. Clin Exp Metastasis 2004;21(7):581-5.
15. Mikolajczyk SD, Song Y, Wong JR, Matson RS, Rittenhouse HG. Are multiple markers the future of prostate diagnostics? Clin Biochem 2004;37:519-28.
16. 1 Signal Peptide Variant Increases Secretion in Vitro and Is Associated with Increased Incidence of Invasive Breast Cancer. Cancer Res 2003;63:2610-5.
17. Taneja TK, Shama SK. Markers of small cell lung cancer. World J Sur Oncol 2004;2:10-8.
18. Esteva FJ, Hortobagyi GN. Prognostic molecular markers in early breast cancer. Breast Cancer Res 2004;6:109-18.
19. Jänne PA, Engelman JA, Johnson BE. Epidermal Growth Factor Receptor Mutations in Non-Small-Cell Lung Cancer: Implications for Treatment and Tumor Biology. J Clin Oncol 2005;23:3227-34.
20. Giaccone G. Epidermal Growth Factor Receptor Inhibitors in the Treatment of Non-Small-Cell Lung Cancer. J Clin Oncol 2005;23:3235-42.